AGTC Stock - Applied Genetic Technologies Corporation
Unlock GoAI Insights for AGTC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $325,000 | $500,000 | $2.45M | $41.69M | $24.19M |
| Gross Profit | $325,000 | $500,000 | $2.45M | $41.69M | $24.19M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $-66,269,000 | $-58,451,000 | $-46,942,000 | $-4,350,000 | $-22,384,000 |
| Net Income | $-71,424,000 | $-57,829,000 | $-45,892,000 | $-2,006,000 | $-21,300,000 |
| Net Margin | -21976.6% | -11565.8% | -1870.9% | -4.8% | -88.1% |
| EPS | $-1.59 | $-1.77 | $-2.17 | $-0.11 | $-1.18 |
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.
Visit WebsiteEarnings History & Surprises
AGTCEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2022 | Nov 21, 2022 | $-0.28 | $-0.28 | 0.0% | = MET |
Q3 2022 | Sep 27, 2022 | $-0.34 | $-0.36 | -5.9% | ✗ MISS |
Q2 2022 | May 16, 2022 | $-0.43 | $-0.33 | +23.3% | ✓ BEAT |
Q1 2022 | Feb 14, 2022 | $-0.38 | $-0.45 | -18.4% | ✗ MISS |
Q4 2021 | Nov 9, 2021 | $-0.35 | $-0.40 | -14.3% | ✗ MISS |
Q3 2021 | Sep 23, 2021 | $-0.40 | $-0.28 | +30.0% | ✓ BEAT |
Q2 2021 | May 17, 2021 | $-0.41 | $-0.40 | +2.4% | ✓ BEAT |
Q1 2021 | Feb 11, 2021 | $-0.59 | $-0.60 | -1.7% | ✗ MISS |
Q4 2020 | Nov 16, 2020 | $-0.53 | $-0.60 | -13.2% | ✗ MISS |
Q3 2020 | Sep 9, 2020 | $-0.48 | $-0.56 | -16.7% | ✗ MISS |
Q2 2020 | May 13, 2020 | $-0.55 | $-0.50 | +9.1% | ✓ BEAT |
Q1 2020 | Feb 5, 2020 | $-0.61 | $-0.47 | +23.0% | ✓ BEAT |
Q4 2019 | Nov 12, 2019 | $-0.60 | $-0.64 | -6.7% | ✗ MISS |
Q3 2019 | Sep 26, 2019 | $-0.54 | $-0.58 | -7.4% | ✗ MISS |
Q2 2019 | May 7, 2019 | $-0.58 | $0.63 | +208.6% | ✓ BEAT |
Q1 2019 | Feb 7, 2019 | $-0.68 | $-0.23 | +66.2% | ✓ BEAT |
Q4 2018 | Nov 8, 2018 | $-0.39 | $0.07 | +117.9% | ✓ BEAT |
Q3 2018 | Sep 10, 2018 | $-0.17 | $-0.37 | -117.6% | ✗ MISS |
Q2 2018 | May 8, 2018 | $-0.41 | $-0.45 | -9.8% | ✗ MISS |
Q1 2018 | Feb 9, 2018 | $-0.19 | $-0.29 | -52.6% | ✗ MISS |
Latest News
Frequently Asked Questions about AGTC
What is AGTC's current stock price?
What is the analyst price target for AGTC?
What sector is Applied Genetic Technologies Corporation in?
What is AGTC's market cap?
Does AGTC pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to AGTC for comparison